UTI Value fund Fund Direct Growth

UTI Value fund Fund Direct Growth

Equity

Direct

Value

NAV as on 04-10-2024

₹ 187.4

-1.7%

1D

Inception Returns

16.2%

/yr

About the Fund

UTI Value fund Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Amit Premchandani. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. UTI Value fund Fund Direct Growth has ₹10543 Cr worth of assets under management (AUM) as on Aug 2024 and is more than category average.
  2. The fund has an expense ratio 1.1.

Returns

UTI Value fund Fund Direct Growth has given a CAGR return of 16.20% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 48.83%, 21.09% and 24.82% respectively.

Holdings

UTI Value fund Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Financial Services, Tech, Consumer Cyclical, Health, Basic Materials, Communication, Government, Energy, Industrial, Consumer Defensive, Utilities, Real Estate. Its top holdings are HDFC Bank Ltd, Infosys Ltd, ICICI Bank Ltd, Bharti Airtel Ltd, Axis Bank Ltd

Taxation

As it is a value mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

Investment objective of UTI Value fund Fund Direct Growth

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies across market capitalization spectrum. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. UTI Value fund Fund Direct Growth has no lock in period.

Historical NAV & Returns

Annualised

zero opening, trading, fund transfer fee
840 people have invested ₹ 1.1Cr in UTI Value fund Fund Direct Growth in the last three months

INDmoney Rank

Powered by IND quant engine
7
/11
50% Performance
38% Risk Management
51% Cost
7 out of 11 among value
img
Larger AUM within category
img
Beats FD returns for both 3Y & 5Y
img
No bad points found for this fund.

Fund Overview

Expense ratio1.14%
Benchmark
S&P BSE 500 India TR INR
AUM₹10543 Cr
Inception Date1 January, 2013
Min Lumpsum/SIP₹5000/₹500
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
34%
STCGRedeeming before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Trailing Returns

as on (04-Oct-24)

Period
UTI Value fund Fund Direct Growth
Nifty 500
value
1M
0.9%
-0.9%
-0.7%
3M
7.6%
2.7%
4.7%
6M
26.1%
13.9%
17.6%
1Y
48.8%
37.4%
46.2%
3Y
21.1%
15.7%
21.7%
5Y
24.8%
21%
24.4%

Fund Distribution

as on (31-Aug-24)

  • Equity 96.7%

  • Debt & Cash 3.3%

Large cap
64.1%

Small cap
17.3%

Mid cap
14.7%

Sector Allocation

Aug'24

Jul'24

Jun'24

Financial Services
30.8%
Tech
11.9%
Consumer Cyclical
11.8%
Health
10%
Basic Materials
9.4%
Communication
6.4%
Energy
5.3%
Industrial
5.3%
Consumer Defensive
3.8%
Utilities
3.6%
Real Estate
1.6%
All changes are between Jun'24 and Aug'24
Aug'24
Jul'24
Jun'24
Fund Returns
2.83%
5.20%
9.16%
Nifty 500
0.97%
3.53%
3.50%
  • This fund’s returns stands at 2.83% whereas the fund’s underlying benchmark Nifty 500 returns stands at 0.97% as on Aug'24
  • This fund outperformed Nifty 500 by 1.86% in Aug'24
Parameters
Aug'24
Jul'24
Jun'24
AUM
₹ 10.4K Cr
₹ 10.4K Cr
₹ 9.9K Cr
  • AUM of the fund stands at 10.4K Cr as of Aug'24
  • AUM has remained same between Aug'24 and Jul'24
Top Stocks bought last month
HCL Technologies Ltd's allocation increased from 0.44% to 1.33%
HCL Technologies Ltd's allocation increased from 0.44% to 1.33%
Eris Lifesciences Ltd Registered Shs's allocation increased from 1.11% to 1.31%
Eris Lifesciences Ltd Registered Shs's allocation increased from 1.11% to 1.31%
Glenmark Pharmaceuticals Ltd's allocation increased from 1.35% to 1.49%
Glenmark Pharmaceuticals Ltd's allocation increased from 1.35% to 1.49%
Top Stocks sold last month
ICICI Bank Ltd's allocation decreased from 5.16 % to 5.13 %
ICICI Bank Ltd's allocation decreased from 5.16 % to 5.13 %
Axis Bank Ltd's allocation decreased from 2.93 % to 2.9 %
Axis Bank Ltd's allocation decreased from 2.93 % to 2.9 %
Kotak Mahindra Bank Ltd's allocation decreased from 2.97 % to 2.87 %
Kotak Mahindra Bank Ltd's allocation decreased from 2.97 % to 2.87 %
Mid Cap allocation has gone down from 14.8% to 14.7%
Mid Cap allocation has gone down from 14.8% to 14.7%
Large Cap allocation has gone down from 65% to 64.1%
Large Cap allocation has gone down from 65% to 64.1%
Small Cap allocation has gone down from 18% to 17.3%
Small Cap allocation has gone down from 18% to 17.3%
Cash allocation has gone up from 2.7% to 3.1%
Cash allocation has gone up from 2.7% to 3.1%
Debt allocation has gone down from 0.2% to 0.2%
Debt allocation has gone down from 0.2% to 0.2%

Top 3 Sectors in August were Financial Services, Consumer Cyclical & Tech

Aug'24
Financial Services
31%
Tech
12%
Consumer Cyclical
12%
Jul'24
Financial Services
31%
Consumer Cyclical
13%
Tech
11%
Fund
Aug'24
Jul'24
No of Holdings
63
63
Top 5 Company Concentration
25.2%
25.2%
Company having highest exposure
HDFC Bank Ltd (8.3%)
HDFC Bank Ltd (8.3%)
No of Sectors
12
12
Top 5 Sectors Concentration
74%
73.2%
Sector having highest exposure
Financial Services (30.8%)
Financial Services (30.9%)
Loading...
We are taking more time than usual
Amit Premchandani
Amit Premchandani
Fund Manager of UTI Value fund Fund Direct Growth, since 1 February 2018
Fund House
UTI Asset Management Co Ltd
Total Schemes
Total AUM
₹2.29L Cr
as on 31-Aug-2024
Address
PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051
Phone
+912266786666
Website
service@uti.co.in

Mutual Fund Insights

Insights icon
This fund expense ratio is slightly on the lower side within the category (value). Its expense ratio is 1.14% which is lower than the category average expense ratio of 1.32%.
Insights icon
Over the last 1 month, this fund has increased expense ratio by 4.6% moving from 1.09 to 1.14.
Insights icon
In the last 3 years, JM Value Fund (Direct) - Growth has given 29.38% return, outperforming this fund by 8.28% per annum.
Insights icon
In the last 1 year, Quant Value Fund Direct Growth has given 66.54% return, outperforming this fund by 17.71%.
Insights icon
In the last 5 years, Bandhan Sterling Value Fund Direct Plan Growth has given 29.41% return, outperforming this fund by 4.58% per annum.
Insights icon
Over the last 6 months, this fund has experienced a 23.2% growth in AUM moving from 8.55K Cr to 10.54K Cr.

UTI Value fund Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 16.2% since inception which is less than its category average return of 19.59%
Fund Allocations

Fund Allocations

This fund has an allocation of 96.75% in Equity, 0.18% in Debt and 3.07% in Cash related instruments
AUM size ₹0 Cr

AUM size ₹0 Cr

This fund has AUM of ₹0 Cr which is more than its category average of ₹ 5554 Cr
Expense Ratio 1.14%

Expense Ratio 1.14%

This fund has an expense ratio of 1.14% which is less than its category average expense ratio of 1.42%

Frequently Asked Questions

The current NAV of UTI Value fund Fund Direct Growth is ₹187.4 as on 04-Oct-2024.
Existing (Absolute + CAGR) as on 04-Oct-2024.
UTI Value fund Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
0.85%
0.85%
6 Month Returns
26.07%
26.07%
1 Year Returns
48.83%
48.83%
3 Years Returns
77.57%
21.09%
5 Years Returns
203.01%
24.82%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.14% as on September 2024
₹10543 Cr as on September 2024
HDFC Bank Ltd(8.31%), Infosys Ltd(5.44%), ICICI Bank Ltd(5.13%), Bharti Airtel Ltd(3.47%), Axis Bank Ltd(2.9%) as on September 2024
Financial Services(29.8%), Tech(11.56%), Consumer Cyclical(11.44%) as on September 2024
The alpha ratio for the UTI Value fund Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
UTI Value fund Fund Direct Growth
6.38
3.18
2.83
As on September 2024
The alpha for UTI Value fund Fund Direct Growth is calculated against S&P BSE 500 India TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the UTI Value fund Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
UTI Value fund Fund Direct Growth
1.01
0.95
0.95
As on September 2024
The Beta for UTI Value fund Fund Direct Growth is calculated with S&P BSE 500 India TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the UTI Value fund Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
UTI Value fund Fund Direct Growth
3.02
1.14
1.04
As on September 2024
The sharpe ratio for UTI Value fund Fund Direct Growth is calculated with S&P BSE 500 India TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the UTI Value fund Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
UTI Value fund Fund Direct Growth
11.75
12.86
18.32
As on September 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 2.3 as on September 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.82 as on September 2024. It tells the consistency of the fund in generating superior risk-adjusted performance
Amit Premchandani is the fund manager of UTI Value fund Fund Direct Growth
The Exit load of UTI Value fund Fund Direct Growth is 1%